FR2751328B1 - Utilisation de nouveaux composes organoselenies comme agents pro-oxydants ainsi que leurs procedes de preparation et des compositions pharmaceutiques en comportant application - Google Patents

Utilisation de nouveaux composes organoselenies comme agents pro-oxydants ainsi que leurs procedes de preparation et des compositions pharmaceutiques en comportant application

Info

Publication number
FR2751328B1
FR2751328B1 FR9608929A FR9608929A FR2751328B1 FR 2751328 B1 FR2751328 B1 FR 2751328B1 FR 9608929 A FR9608929 A FR 9608929A FR 9608929 A FR9608929 A FR 9608929A FR 2751328 B1 FR2751328 B1 FR 2751328B1
Authority
FR
France
Prior art keywords
organoselene
pro
compounds
preparation
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9608929A
Other languages
English (en)
Other versions
FR2751328A1 (fr
Inventor
Jinzhu Xu
Georges Appere
Jean R Chaudiere
Jean Claude Yadan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxis International SA
Original Assignee
Oxis International SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxis International SA filed Critical Oxis International SA
Priority to FR9608929A priority Critical patent/FR2751328B1/fr
Priority to US08/771,442 priority patent/US6001825A/en
Priority to EP97401648A priority patent/EP0819682A1/fr
Priority to CA002216334A priority patent/CA2216334A1/fr
Priority to AU39879/97A priority patent/AU727067B2/en
Publication of FR2751328A1 publication Critical patent/FR2751328A1/fr
Priority to US09/120,436 priority patent/US6057310A/en
Application granted granted Critical
Publication of FR2751328B1 publication Critical patent/FR2751328B1/fr
Priority to US09/329,755 priority patent/US6130212A/en
Priority to US09/648,784 priority patent/US6407083B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D293/00—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms
    • C07D293/10—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D293/12—Selenazoles; Hydrogenated selenazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D293/00—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms
    • C07D293/10—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9608929A 1996-07-17 1996-07-17 Utilisation de nouveaux composes organoselenies comme agents pro-oxydants ainsi que leurs procedes de preparation et des compositions pharmaceutiques en comportant application Expired - Fee Related FR2751328B1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR9608929A FR2751328B1 (fr) 1996-07-17 1996-07-17 Utilisation de nouveaux composes organoselenies comme agents pro-oxydants ainsi que leurs procedes de preparation et des compositions pharmaceutiques en comportant application
US08/771,442 US6001825A (en) 1996-07-17 1996-12-20 Use of novel organoselenium compounds as pro-oxidizing agents their methods of preparation and pharmaceutical compositions and application thereof
EP97401648A EP0819682A1 (fr) 1996-07-17 1997-07-09 Utilisation de composés organoséléniés comme agents pro-oxydants ainsi que leurs procédés de préparation et compositions pharmaceutiques les contenant
CA002216334A CA2216334A1 (fr) 1996-07-17 1997-09-24 Utilisation de composes organoselenium nouveaux comme agents pro-oxydants, methodes de preparation de ces composes, et compositions pharmaceutiques et leur application
AU39879/97A AU727067B2 (en) 1996-07-17 1997-10-02 Use of novel organoselenium compounds as pro-oxidizing agents, their methods of preparation and pharmaceutical compositions and application thereof
US09/120,436 US6057310A (en) 1996-07-17 1998-07-22 Organoselenium compounds with pro-oxidant activity and pharmaceutical use thereof
US09/329,755 US6130212A (en) 1996-07-17 1999-06-10 Use of novel organoselenium compounds as pro-oxidizing agents, their methods of preparation and pharmaceutical compositions and application thereof
US09/648,784 US6407083B1 (en) 1996-07-17 2000-08-28 Uses of novel organoselenium compounds with pro-oxidant activity

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9608929A FR2751328B1 (fr) 1996-07-17 1996-07-17 Utilisation de nouveaux composes organoselenies comme agents pro-oxydants ainsi que leurs procedes de preparation et des compositions pharmaceutiques en comportant application
CA002216334A CA2216334A1 (fr) 1996-07-17 1997-09-24 Utilisation de composes organoselenium nouveaux comme agents pro-oxydants, methodes de preparation de ces composes, et compositions pharmaceutiques et leur application

Publications (2)

Publication Number Publication Date
FR2751328A1 FR2751328A1 (fr) 1998-01-23
FR2751328B1 true FR2751328B1 (fr) 1998-10-09

Family

ID=25679635

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9608929A Expired - Fee Related FR2751328B1 (fr) 1996-07-17 1996-07-17 Utilisation de nouveaux composes organoselenies comme agents pro-oxydants ainsi que leurs procedes de preparation et des compositions pharmaceutiques en comportant application

Country Status (4)

Country Link
US (2) US6001825A (fr)
EP (1) EP0819682A1 (fr)
CA (1) CA2216334A1 (fr)
FR (1) FR2751328B1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000058281A1 (fr) * 1999-03-31 2000-10-05 Daiichi Pharmaceutical Co., Ltd. Substrats pour thioredoxine reductase
NO20001360D0 (no) * 2000-03-15 2000-03-15 Thin Film Electronics Asa Vertikale elektriske forbindelser i stabel
EP2070942A1 (fr) * 2007-12-13 2009-06-17 Bayer Schering Pharma Aktiengesellschaft Procédé d'aromatisation de 19-nor-androst-4-en-3-ons en estra-1,3,5(10)-triènes
WO2015181116A1 (fr) * 2014-05-26 2015-12-03 Crystal Pharma, S.A.U. Procédé et intermédiaires pour la préparation de stéroïdes 7-alkylés
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3027074A1 (de) * 1980-07-17 1982-02-18 A. Nattermann & Cie GmbH, 5000 Köln Benzisoselenazolon enthaltende pharmazeutische praeparate und ihre verwendung
FR2718441B1 (fr) * 1994-04-07 1996-06-28 Bioxytech Nouveaux composés de structure benzisoséléna-zoline et -zine, leur procédé de préparation et leurs applications thérapeutiques.

Also Published As

Publication number Publication date
CA2216334A1 (fr) 1999-03-24
US6001825A (en) 1999-12-14
FR2751328A1 (fr) 1998-01-23
US6057310A (en) 2000-05-02
EP0819682A1 (fr) 1998-01-21

Similar Documents

Publication Publication Date Title
IS2058B (is) Ný taxóíð, aðferð til framleiðslu þeirra og lyfjasamsetningar sem innihalda þau
NO20004311D0 (no) Farmasøytisk sammensetning av topiramat
FI973279A0 (fi) Uudet farnesyylitransferaasin inhibiittorit, niiden valmistus ja niitä sisältävät farmaseuttiset koostumukset
NO990685L (no) FremgangsmÕte ved inkubering av u°nsket smak i orale sammensetninger
AU1307299A (en) Stable pharmaceutical compositions including ascorbic acid and methods of using same
DE69635929D1 (de) Klebstoffzusammensetzungen und methoden zu ihrer verwendung
MX9206953A (es) Composiciones fisiologicas de lagrima y metodos para su preparacion
NO984878D0 (no) Fremstilling og anvendelse som medikamenter av 3-alkoksypyridin-2-karboksylsyreamidestere
EE200100007A (et) Kinoliini derivaadid, nende kasutamine ravimina, neid sisaldavad farmatseutilised kompositsioonid ning ühendite ja farmatseutiliste kompositsioonide kasutamine patoloogilisest põletikust ja autoimmuunsusest tingitud haiguste ravis
MA23735A1 (fr) Preparation et application des derives pyrroliques entant que medicaments
NO992875L (no) Fremstilling av enantiomert anriket threo-metylfenidat
NO962491D0 (no) Orale formuleringer av S(+)-etodolac
EP1181022A4 (fr) Compositions medicinales et leur procede de preparation
DZ2174A1 (fr) Mélanges isolables à partir de graines d'eugénia jambolana lamarck, ieur préparation et l'utilisation de ces mélanges et certains de leurs constituants comme médicaments.
EE200000226A (et) 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon
PL337064A1 (en) Method of and compositions for orally administering taxanes to human beings
EE9900034A (et) Arüültsükloalkaankarboksüülestrid, nende kasutamine, farmatseutilised kompositsioonid ja valmistamine
FR2751328B1 (fr) Utilisation de nouveaux composes organoselenies comme agents pro-oxydants ainsi que leurs procedes de preparation et des compositions pharmaceutiques en comportant application
PT1140110E (pt) Clatratos de desidroepiandrosterona e correspondentes composicoes farmaceuticas
NO971329D0 (no) Fosforsyrreestere av alkyl- og acyl-dianhydro-1,4:3,6-D-glucitol, deres fremstilling og anvendelse
PT826679E (pt) Compostos de naftilo intermediarios composicoes e metodos de utilizacao
AU2482897A (en) Moisture containing compositions that are spreadable onto and adherable to biomembranes, methods of making and use thereof
AU2913395A (en) Compositions and methods of making and using human full length trk-b
MA26670A1 (fr) Compositions pharmaceutiques comprenant des inhibiteurs de nos, leur preparation et leur utilisation
NO20003138D0 (no) Ny anvendelse av lokalanestetika mot vaskulær hodepine

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse